Business Description
Founded in 1999 and based in Seongnam-si, South Korea, iNtRON Biotechnology researches and builds new medicines that use naturally occurring viruses and proteins to fight bacterial infections. The company applies two proprietary platforms, itLysin and IMPA, to advance this work. Its goal is to bring effective treatments to patients through a science-driven approach to drug development.
